Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Taisho Pharmaceutical Co., Ltd.

https://www.taisho.co.jp/

Latest From Taisho Pharmaceutical Co., Ltd.

Hikma Could Consider Exit Strategy For Generics Business

Hikma says all options are on the table for its beleaguered generics business, with an immediate sale unlikely but the door open for a longer-term exit strategy. Meanwhile, the firm has also offered an update on recruitment for a new CEO.

Strategy Generic Drugs

Hikma Adds Another Celltrion Biosimilar To MENA Collaboration

Hikma has further expanded its portfolio of biosimilars in the MENA region with the addition of Celltrion’s Vegzelma bevacizumab rival to Avastin. Meanwhile, Hikma has also just launched a new pre-filled syringe version of naloxone in the US.

Deals Biosimilars

Hikma Delivers On Authorized Xyrem In US

Hikma has begun 2023 with the long-awaited launch of a US authorized generic version of Xyrem (sodium oxybate). Meanwhile, the company has also struck a deal with Junshi Biosciences for toripalimab in the MENA region.

Launches Generic Drugs

Pfizer’s Gene Therapy Asset Chases UniQure/CSL’s Hemgenix After Pivotal Hemophilia B Success

Pfizer’s fidanacogene elaparvovec has hit the mark in a Phase III hemophilia B trial just a month after rival UniQure’s Hemgenix won US approval, with Pfizer’s plans for regulatory action raising the stakes for Hemgenix.

Clinical Trials Blood & Coagulation Disorders
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
      • Transdermal
  • Other Names / Subsidiaries
    • Hoepharma Holdings Sdn. Bhd.
    • Taisho Toyama Pharmaceutical Co., Ltd.
    • TOKUHON Corporation
    • UPSA SAS
UsernamePublicRestriction

Register